●Molecular Stability
Synthetic oxytocin mirrors the natural hormone but is synthesized to resist enzymatic degradation, ensuring a longer half-life. This stability allows controlled administration via intravenous (IV) or intramuscular (IM) routes.
●Receptor Specificity
Oxytocin binds to G protein-coupled receptors (OXTR) in uterine myometrium and mammary glands. During pregnancy, OXTR expression surges 100–200-fold, priming the uterus for contractions.
●Dose-Dependent Effects
Low doses initiate rhythmic contractions, mimicking natural labor. High doses may cause sustained, tetanic contractions, posing fetal risks.
●Rapid Clearance
Its short half-life (3–12 minutes) necessitates continuous IV infusion for sustained effect, allowing quick adjustment in emergencies.
